Abbott

AbbottAt Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

www.abbott.com

Abbott RSS Channel

Display # 
Title Published Date
What's the secret to living a full life? A new global survey reveals family comes first 27 April 2016
Abbott's Absorb, the first fully dissolving heart stent, earns positive review by FDA advisory committee 17 March 2016
Abbott to Acquire Alere, becoming leader in point of care testing 01 February 2016
Abbott and UC San Francisco discover new virus is linked to hepatitis C 14 December 2015
'Science' says Abbott is a Top Employer 30 October 2015
Abbott is asking one million people worldwide. Here's why and how. 22 September 2015
Abbott named industry leader for responsible and sustainable business for three consecutive years on the Dow Jones Sustainability Index (DJSI) 11 September 2015
Abbott completes acquisition of Veropharm 12 December 2014
Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan 14 July 2014
Abbott to acquire Veropharm 23 June 2014
Abbott enhances its position in fast-growing Latin American market 18 May 2014
Abbott reports first-quarter 2014 results 16 April 2014
Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China 10 April 2014
Abbott reports fourth-quarter and full-year 2013 results 22 January 2014
Experience a day in the life of an insulin-using patient with diabetes through interactive infographic 14 November 2013
Abbott reports third-quarter 2013 results 16 October 2013
Abbott reports first-quarter 2013 results 17 April 2013
Abbott to collaborate with Janssen and Pharmacyclics 21 February 2013
Abbott initiates clinical trial of Absorb TM in the United States 08 January 2013
Abbott completes separation of research-based pharmaceuticals business 02 January 2013

Most Popular Now

New antibiotic Zavicefta approved i…

AstraZeneca today announced that the European Commission (EC) has granted marketing authorisation for Zavicefta (ceftazidime-avibactam, previously known as CAZ AVI), a ne...

Read more

Novo Nordisk and Aarhus University …

Novo Nordisk and Aarhus University's Science and Technology faculty today signed a collaboration agreement to strengthen protein technology research and development. Unde...

Read more

AstraZeneca enters licensing agreem…

AstraZeneca today announced that it has entered into agreements that support its strategic focus on three main therapy areas; Respiratory, Inflammation and Autoimmunity, ...

Read more

Novartis adds bispecific antibodies…

Today Novartis announced that it has entered into a collaboration and licensing agreement with Xencor for the development of bispecific antibodies for treating cancer. Th...

Read more

Bristol-Myers Squibb and PsiOxus Th…

Bristol-Myers Squibb Company (NYSE: BMY) and PsiOxus Therapeutics, Ltd. (PsiOxus) today announced an exclusive clinical collaboration agreement to evaluate the safety, to...

Read more

Bristol-Myers Squibb acquires Cormo…

Bristol-Myers Squibb Company (NYSE:BMY) and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormo...

Read more

Sanofi Pasteur signs research agree…

Sanofi and its vaccines global business unit Sanofi Pasteur announced today a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Resear...

Read more

Laboratory drug trials could lead t…

A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland. Developed by international phar...

Read more

FDA advances Precision Medicine Ini…

In support of the President’s Precision Medicine Initiative, the U.S. Food and Drug Administration has issued two draft guidances that, when finalized, will provide a fle...

Read more

Merck and Pfizer initiate Phase III…

Merck KGaA, Darmstadt, Germany, and Pfizer (NYSE: PFE) have announced the initiation of a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of ave...

Read more

Merck commits €1.5 million to the G…

Merck, a leading science and technology company, today announced it would continue to support the advancement of medical science in the field of fertility through the Gra...

Read more

Twisting and turning to target anti…

Researchers are getting closer to understanding how some natural antibiotics work so they can develop drugs that mimic them. A recent review commissioned by the British g...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

© World Pharma News 2006 - 2016